258 related articles for article (PubMed ID: 6951095)
1. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
Zaharko DS; Ramonas LM
J Natl Cancer Inst; 1982 May; 68(5):875-80. PubMed ID: 6951095
[TBL] [Abstract][Full Text] [Related]
2. Modulation of deoxycytidine metabolism in vivo with high-dose thymidine in mice.
Zaharko DS; Covey JM
J Natl Cancer Inst; 1983 Nov; 71(5):1033-9. PubMed ID: 6580479
[TBL] [Abstract][Full Text] [Related]
3. Dose- and schedule-dependent activation and drug synergism between thymidine and 5-aza-2'-deoxycytidine in a human promyelocytic leukemia cell line.
Grant S; Rauscher F; Margolin J; Cadman E
Cancer Res; 1982 Feb; 42(2):519-24. PubMed ID: 6173114
[TBL] [Abstract][Full Text] [Related]
4. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
Santelli G; Valeriote F
J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic and cytokinetic effects of thymidine, 5-fluorouracil, and deoxycytidine on HeLa cells in culture.
Fried J; Perez AG; Doblin JM; Clarkson BD
Cancer Res; 1981 Jul; 41(7):2627-32. PubMed ID: 7248935
[TBL] [Abstract][Full Text] [Related]
6. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
[TBL] [Abstract][Full Text] [Related]
7. Comparison of in vivo and in vitro effects of continuous exposure of L1210 cells to 6-thioguanine.
Maybaum J; Morgans CW; Hink LA
Cancer Res; 1987 Jun; 47(12):3083-7. PubMed ID: 3581060
[TBL] [Abstract][Full Text] [Related]
8. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
Ross DD; Akman SA; Schrecker AW; Bachur NR
Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
[TBL] [Abstract][Full Text] [Related]
9. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells.
Balzarini J; De Clercq E
Acta Biochim Pol; 1987; 34(2):63-77. PubMed ID: 2823514
[TBL] [Abstract][Full Text] [Related]
10. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
Balzarini J; De Clercq E
Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422
[TBL] [Abstract][Full Text] [Related]
11. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
Momparler RL; Veselý J; Momparler LF; Rivard GE
Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of poly(adenosine diphosphate-ribose) polymerase by thymidine and thymidine analogues in L1210 cells and its relationship to the potentiation of the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea but not of 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine.
August EM; Cooper DL; Prusoff WH
Cancer Res; 1991 Mar; 51(6):1586-90. PubMed ID: 1900213
[TBL] [Abstract][Full Text] [Related]
13. Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717.
Jackman AL; Taylor GA; Calvert AH; Harrap KR
Biochem Pharmacol; 1984 Oct; 33(20):3269-75. PubMed ID: 6487375
[TBL] [Abstract][Full Text] [Related]
14. Deoxyribonucleoside-induced selective modulation of cytotoxicity and mutagenesis.
Peterson AR; Danenberg PV; Ibric LL; Peterson H
Basic Life Sci; 1985; 31():313-34. PubMed ID: 3158302
[TBL] [Abstract][Full Text] [Related]
15. Characterization of tumor cell heterogeneity of a murine leukemia cell line (L1210) in response to arabinosylcytosine: quantitation using a computerized image analysis system.
Raymakers RA; Slocum HK; Minderman H; Malmberg M; Rustum YM
Exp Hematol; 1993 May; 21(5):602-7. PubMed ID: 8513859
[TBL] [Abstract][Full Text] [Related]
16. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
Klubes P; Cerna I
Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
[TBL] [Abstract][Full Text] [Related]
17. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
Samuels LL; Straw JA
Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
[TBL] [Abstract][Full Text] [Related]
18. Rescue of thymidine cytotoxicity in L1210 ascites by elevated endogenous levels of deoxycytidine.
Egan EM; Sargent L; Rosowsky A; Kufe DW
Cancer Treat Rep; 1981; 65(9-10):853-60. PubMed ID: 7273018
[TBL] [Abstract][Full Text] [Related]
19. Effects of dose and duration of exposure on 5-aza-2'-deoxycytidine cytotoxicity for L1210 leukemia in vitro.
Covey JM; Zaharko DS
Cancer Treat Rep; 1984 Dec; 68(12):1475-81. PubMed ID: 6210141
[TBL] [Abstract][Full Text] [Related]
20. Effects on the monocyte-macrophage system and antitumor activity against L1210 leukemia of cis-bis-cyclopentenecarboxylato-trans-R,R-1,2-diaminocyclohexane -platinum (II) encapsulated in multilamellar vesicles.
Perez-Soler R; Khokhar AR; Claringbold P; Kasi LP; Lopez-Berestein G
J Natl Cancer Inst; 1986 Nov; 77(5):1137-43. PubMed ID: 2430132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
